KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
16.43
+0.03 (0.18%)
Dec 5, 2025, 4:00 PM EST - Market closed
KalVista Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Jul '25 Jul 31, 2025 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 |
| Net Income | -203.1 | -183.44 | -126.64 | -92.91 | -82.34 | -46.24 | |
| Depreciation & Amortization | 0.97 | 0.94 | 0.82 | 0.72 | 0.56 | 0.54 | |
| Loss (Gain) From Sale of Investments | -1.83 | -1.55 | -1.23 | 1.13 | 3.15 | 0.53 | |
| Stock-Based Compensation | 14.63 | 12.29 | 21.92 | 9.92 | 11.09 | 7.12 | |
| Other Operating Activities | 9.49 | 3.82 | 0.75 | -1.53 | 1.73 | -0.46 | |
| Change in Accounts Receivable | -1.93 | - | - | - | - | - | |
| Change in Accounts Payable | -3.96 | -4.97 | 4.32 | 1.11 | 1.69 | 0.15 | |
| Change in Unearned Revenue | 11.05 | 10.56 | - | - | - | - | |
| Change in Other Net Operating Assets | 7.48 | 9.45 | 10.85 | 6.31 | -14.01 | 8.2 | |
| Operating Cash Flow | -167.19 | -152.91 | -89.23 | -75.26 | -78.13 | -30.17 | |
| Capital Expenditures | -0.7 | -0.43 | -0.04 | -1.2 | -0.93 | -0.08 | |
| Sale (Purchase) of Intangibles | -0.58 | -0.5 | -0.4 | - | - | - | |
| Investment in Securities | 76.4 | 91.95 | -84.28 | 42.61 | 58.79 | -147.57 | |
| Investing Cash Flow | 75.12 | 91.02 | -84.72 | 41.42 | 57.86 | -147.65 | |
| Issuance of Common Stock | 59.98 | 61.69 | 97.59 | 57.03 | 1.58 | 212.12 | |
| Other Financing Activities | 119.96 | 98.04 | 53.12 | 1.09 | - | - | |
| Financing Cash Flow | 179.94 | 159.73 | 150.71 | 58.12 | 1.58 | 212.12 | |
| Foreign Exchange Rate Adjustments | 5.25 | 2.64 | -1.21 | 1.24 | -1.17 | 0.51 | |
| Net Cash Flow | 93.12 | 100.48 | -24.45 | 25.51 | -19.86 | 34.8 | |
| Free Cash Flow | -167.89 | -153.34 | -89.27 | -76.46 | -79.07 | -30.25 | |
| Free Cash Flow Margin | -11773.63% | - | - | - | - | - | |
| Free Cash Flow Per Share | -3.26 | -3.09 | -2.43 | -2.74 | -3.23 | -1.58 | |
| Levered Free Cash Flow | -100.21 | -92.91 | -50.27 | -52.01 | -60.09 | -21.2 | |
| Unlevered Free Cash Flow | -94.39 | -89.29 | -50.27 | -52.01 | -60.09 | -21.2 | |
| Change in Working Capital | 12.65 | 15.04 | 15.17 | 7.41 | -12.32 | 8.35 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.